Domestic corporations of multinational pharmaceutical companies are gaining a benefit due to domestic companies chllange to develop biosimilar

It was identified that domestic corporations of multinational pharmaceutical companies which hold original biomedicine are gaining a benefit due to domestic companies chllange to develop biosimilar.

Multinational pharmaceutical companies which hold original biomedicine are of cource not delighted to see development of biosimilar. However, they will be able to enjoy a short-term effect of incre...